News

Jingzhou Minkang Biotechnology Co., Ltd.

Located in Jingzhou City, Hubei Province, is a pioneer in China's medical products industry. As a bio-pharmaceutical technology development company integrating R&D, production, and sales, Minkang Biotechnology has long been committed to advancing the cause of green health. The company is recognized as a Model Enterprise for Modernization of Traditional Chinese Medicine in Hubei Province and a National High-Tech Enterprise.

The company's technical management team comprises 7 professors, 2 Ph.D. holders, 2 master's degree holders, and numerous bachelor's degree talents. Key technical management personnel all hold associate degrees or higher and are members of the Hubei Provincial Academician and Expert Workstation.

Minkang Biotechnology has established collaborative platforms with multiple universities and research institutes to conduct technical cooperation and product development. The company has obtained 15 authorized patents, including 12 invention patents, and has another 10 invention patent applications currently under review. Its patented "Industrialized Farming Technology for Medical Leeches" has passed expert appraisal organized by the Provincial Department of Science and Technology, achieving a domestically leading technological level. This technology has been awarded a Major Scientific and Technological Achievement of Hubei Province and the Third Prize for Science and Technology Progress of Jingzhou City.

Minkang Biotechnology possesses the largest leech population in China and is the nation's sole large-scale, standardized, and industrialized leech farming enterprise. Its proprietary leech breeding process, with fully independent intellectual property rights, enables the complete artificial breeding of leeches throughout their lifecycle, filling multiple technological gaps in the field of Hirudo nipponica farming in China. Currently, the company maintains the largest Hirudo nipponica population domestically, with an annual production of 100 million individuals and a fresh weight exceeding 100 tons.

Medical leeches are the core product of Minkang Biotechnology. They possess the efficacy of breaking blood stasis to unblock channels, and dispelling stasis to reduce masses. They can be used to treat conditions such as amenorrhea due to blood stasis, abdominal masses and lumps, stroke-induced hemiplegia, and traumatic injuries. Yizhilin is the independent brand of Minkang Biotechnology, featuring a series of independently developed health products. These include leech slices, leech capsules, leech essence liquid, leech moisturizing masks, turmeric-schisandra-poria capsules, "Yi Tie Xiao" patches, hemorrhoid gel, "Yan Lei" products, and begonia vine tea.

As a leading brand in China's leech industry, Yizhilin is dedicated to improving the national health index and addressing the repair and prevention of common skin issues. Its products demonstrate good clinical efficacy in the hospital medication sector, while also meeting the demands of the broader health market in the dietary supplement field. Minkang Biotechnology sincerely invites business partners, offering comprehensive support and guarantees to its agents to jointly create a better future.